Log in with Linkedin

Log in with Facebook

Log in with emailForgot password?


Join with LinkedIn

Join with Facebook



Dr. Kelle Moley is the Deputy Director of the new Division of Reproductive Health Technologies, Global Health at the Bill and Melinda Gates Foundation. In this role, she will focus on reproductive health in women and girls throughout their life course in low and middle income countries. Her task will be to discover new technologies to improve their lives with respect to helping make informed family planning decisions, providing safe and reliable protection against sexually transmitted infections including HIV, stopping preventable preterm birth and empowering women and girls to live healthier and happier lives. Prior to this new position starting July 1, 2020, she served as the Chief Scientific Officer and Senior Vice President of Research and Global Programs at March of Dimes. Kelle is an Obstetrician/Gynecologist and was the Vice Chair and the Chief of the Division of Basic and Translational Science Research in the Department of Obstetrics and Gynecology, at Washington University in St. Louis, USA where she spent her entire 30-year academic career. There, she was also the Director of the Center for Reproductive Health Sciences also at Washington University. As an independent physician-scientist for the last 25 years, her work has impacted our understanding of reproductive performance, glucose metabolism and embryo development in diabetic and obese animal models and this is directly applicable to the pathophysiology of diabetes related disorders in their offspring. She has over 150 peer-reviewed scientific articles in the area of maternal and child health. In addition to her research endeavors, she is the former Co-Director of the Washington University Institute of Clinical and Translational Sciences and was the Fellowship Director of Reproductive Endocrinology and Infertility for 12 years. She was the President of the Society of Reproductive Investigation in 2013-14 and was the Chair of the NIH Standing study section “Pregnancy and Neonatology” from 2011-2014. She also the past Principal Investigator of the national NIH K12 Reproductive Scientist Development Program, which resides at Washington University in St. Louis. Finally, she was elected to the National Academy of Medicine in 2014.

Site Disclaimer

By using this website (the “Site”), you are subject to our Terms of Use and our Privacy Policy. Please read these carefully before proceeding.

The Discovery page offers users the opportunity to preview early-stage companies, which may be under consideration for fundraising on the RedCrow INVEST platform. These companies are not currently raising capital on our Site, and we may not have performed any due diligence or verified that the information they’ve posted is accurate.

Companies actively raising money on our Site are listed on the INVEST platform. Securities are offered through JumpStart Securities, LLC, a registered broker/dealer and FINRA/SIPC member.

RedCrow is not an investment adviser. Listings on the RedCrow site do not imply a recommendation or endorsement by RedCrow.